Check-Cap (NASDAQ:MBAI) Stock Price Down 0.7% – Here’s What Happened

Shares of Check-Cap Ltd (NASDAQ:MBAI) traded down 0.7% during trading on Thursday . The stock traded as low as $8.33 and last traded at $8.83. 57,301 shares traded hands during trading, a decline of 37% from the average daily volume of 91,578 shares. The stock had previously closed at $8.89.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Check-Cap in a research report on Tuesday, July 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Check-Cap Stock Down 0.7%

The company has a market capitalization of $83.53 million, a price-to-earnings ratio of -4.39 and a beta of 0.68. The business has a 50-day moving average price of $8.36 and a 200-day moving average price of $10.63.

About Check-Cap

Check-Cap Ltd. (NASDAQ: MBAI) is an Israel-based medical technology company focused on non-invasive screening solutions for colorectal cancer. The company develops an ingestible imaging capsule and associated detection system intended to provide a patient-friendly alternative to traditional colonoscopy and CT colonography for colorectal screening and polyp detection.

Check-Cap’s technology centers on a swallowable capsule that acquires images of the colon as it traverses the gastrointestinal tract; external detectors capture the transmitted signals and software reconstructs images for clinical review.